Further validation studies revealed the interaction of DLGAP5 with MYC and its facilitation of MYC deubiquitination via USP11, thereby increasing glycolytic levels in BLCA cells. This evidence concerns the gene DLGAP5 and bladder transitional cell carcinoma.